Anti-Neoplastic Drugs, Pt. 5 Flashcards

1
Q

What is apoptosis? What begins the signal to start this process?

A

regulated process of programmed cell death that depends on the balance of pro-apoptotic and pro-survival signals

internal surveillance molecules detect damaged DNA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are the 3 biochemical events of apoptosis? What happens at the very end?

A
  1. cell shrinkage
  2. chromatin condensation
  3. DNA fragmentation

cells are converted into vesicles (apoptotic bodies) that can be removed by macrophages

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What 3 things do cancer cells do to avoid apoptosis?

A
  1. alter pro-apoptotic proteins that detect problems and induce apoptosis (caspases, Bad, Bax, Bak, Noxa, Puma)
  2. overproduces anti-apoptotic proteins (BCL2, MCL1, BAG3, HSP27, HSP70, survivin)
  3. create mutant proteins
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are the 2 pathways of apoptosis? How do they come together?

A
  1. extrinsic - apoptosis-inducing ligand binds to death receptors to activate Caspases
  2. intrinsic - p53, Bax, and Bak induce mitochondrial activation of cytochrome C and Caspases

execution phase - caspases induce apoptosis
(anti-cancer cells want to activate apoptosis in cancer cells)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is the goal in targeting apoptotic pathways with anti-neoplastics? What are the 2 main types of drugs to do this?

A

switch the balance towards cell death for cancer cells

  1. drugs that directly activate pro-apoptotic pathways (Bax, Bak, Bad, Bok) to cause apoptosis
  2. drugs that deactivate anti-apoptotic proteins (BCL2, BCL-XL) present in cancer cells
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is the mechanism of action of Palladia? What is its main use?

A

tyrosine kinase inhibitor that has both direct antitumor and anti-angiogenic activity

FDA-approved for dogs with grade II or III recurrent cutaneous mast cell cancer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are 5 adverse effects of Palladia?

A
  1. loss of appetite
  2. nausea/vomiting
  3. diarrhea
  4. low leukocytes
  5. protein loss through kidneys
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is the mechanism of action of Laversia-CA1? What is it used to treat?

A

first small-molecule selective inhibitor of nuclear export (SINE) that targets and binds to exportin-1 (XPO1) transporter

first and ONLY oral tablet to treat lymphoma in dogs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What off-label targeted therapy is available as an apoptotic in cats? How is it used?

A

Gleevac

binds and inhibits several protein-tyrosine kinases in squamous cell carcinoma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is angiogenesis? What does it do in adults?

A

blood vessel formation taking place early in development

promotes wound healing and supports female reproductive system in pregnancy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

On a cellular level, when does angiogenesis occur? How do cells do this?

A

when cells are in need of nutrients and oxygen

cell releases proteins that bind to special receptors on the surface of endothelial cells that make up the lining of vessels

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What provides nutrients and oxygen to tumors? How are the cancer cells able to do this?

A

tumor blood vessels

produce high levels of proteins, like VEGF*, MMPs, and HIF-1α that bind to receptors on endothelial cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is the goal of anti-angiogenic therapy? What 3 types of drugs are used?

A

block angiogenesis to starve tumor cells

  1. drugs that interfere with any tumor cells (indirect inhibitors) and tumor endothelial cells (direct inhibitors)
  2. drugs that target pro-angiogenic proteins released by the tumor
  3. drugs that target endothelial receptors
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is thought to be the ideal strategy for cancer therapy? Why?

A

anti-angiogenics that can target all cancers, since endothelial cells will be the same in all cancers

less drug resistance will occur since endothelial receptors are genetically stable

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What are the 2 main anti-angiogenics? How do they work?

A
  1. Bevacizumab (Avastin) - anti-VEGF antibody that blocks it from binding to the endothelial receptor
  2. Sorafenib (Nexavar) - small molecule inhibitor that targets VEGF-R and multiple kinase activity on endothelial receptors
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Which anti-angiogenics are thought to be efficacious in inhibiting the growth of canine sarcomas?

A

monoclonal antibodies - Avastin (Bevacizumab)

17
Q

How are MMPs, thrombospondin, angiostatin, and endostatin used as anti-angiogenics?

A

inhibits basement membrane degradation

inhibits cell migration, proliferation, adhesion, and survival of endothelial receptors

inhibits cell proliferation and induces apoptosis of endothelial receptors

inhibits cell migration, cell proliferation, and survival of endothelial receptors

18
Q

How does immunotherapy work? What 3 side effects differ from those commonly seen in other types of cancer treatment?

A

trains the immune system to attack cancer rather than attacking the cancer directly - blocks tumor cells from deactivating T-cells

  1. fatigue
  2. inflammation of skin, lungs (cough, chest pains), and colon (abdominal pain, diarrhea)
  3. endocrine: diabetes, pituitary gland inflammation
19
Q

In what 3 ways do tumors trick T-cells?

A
  1. tumor does not produce antigens —> T-cells cannot recognize the tumor
  2. tumor has MHC mutations —> T-cells cannot recognize the tumor
  3. tumor produces immunosuppressive proteins —> T-cell activation is inhibited
20
Q

How does cancer immunotherapy work:

A

interferes with T cell and cancer cell communication to keep T cells active

  • cancer cells exhibit PDL1, which inhibits the immune checkpoint protein PD-1 on T-cells, and inactivates them
  • checkpoint inhibitors are able to block this pathway to release the breaks, allowing T cells to fight
21
Q

What 3 immunotherapies are FDA-approved for use in some tumors? How do they work?

A
  1. Ipilimumab - IgG anti-CTLA-4 antibody (melanoma)
  2. Nivolumab - IgG4k anti-PD-1 antibody
  3. Pembrolizumab - IgG4k anti-PD-1 antibody
22
Q

What is being targeted as a possible treatment against advanced spontaneous cancers in dogs? What cancer is this being used against? What type of therapy seems the most promising?

A

PD-L1 expression

malignant melanomas

monoclonal antibody immunotherapy

23
Q

How does oncolytic viral therapy work?

A

virus against tumor is injected (typically into CCSF) allowing it to selectively infect and kill cancer cells and induces an immune response to the virus

24
Q

What are the 2 approaches to adaptive T cell therapy?

A
  1. resected tumor sample is digested into a single cell suspension and cultured in the presence of IL-2 to select for naturally occurring tumor-infiltrating lymphocytes that are then expanded, tested for anti-tumor activity, and reinfused into the patient
  2. T-cells are harvested from the blood and either a transgenic T-cell receptor or a chimeric antigen receptor is introduced by viral or non-viral transduction, making the cells now able to recognize the tumor and fight it
25
Q

What is the mechanism of anti-cancer vaccines? How does it work therapeutically? What therapeutic vaccine is available in dogs?

A

activates the body’s immune system to recognize and kill cancer cells (doesn’t work on a particular target)

used after disease begins to use APC (dendritic cells) to activate T cells

DNA vaccine for canine melanoma is in trials

26
Q

How are anti-cancer vaccines able to activate the immune system? What 5 challenges are there?

A

vaccines present tumor-associated antigens to T-cells that then are activated and travel to tumor cells and induce cell death

  1. T-cell tolerance to tumor-associated antigens
  2. dysfunctional antigen presentation
  3. T-cell exhaustion induced by checkpoint inhibitors (PD-1)
  4. immunosuppressive cells in the tumor microenvironment
  5. variable patient response to vaccination
27
Q

What is thought to be the first therapeutic cancer vaccine in veterinary medicine?

A

vaccine for canine oral malignant melanoma

  • has potential to induce an anti-tumor immune response under the right circumstances